2. Signaling Pathways
  3. Others
  4. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (7677):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-W700029
    7-Methyl-1-(methyl-d3)-3,7-dihydro-1H-purine-2,6-dione
    7-Methyl-1-(methyl-d3)-3,7-dihydro-1H-purine-2,6-dione is deuterium-labeled 7-Methyl-1-(methyl-d3)-3,7-dihydro-1H-purine-2,6-dione.
    7-Methyl-1-(methyl-d<sub>3</sub>)-3,7-dihydro-1H-purine-2,6-dione
  • HY-W018587S
    Bis(2-Ethylhexyl)-tetrabromo phthalate-13C6,d34
    Bis(2-Ethylhexyl)-tetrabromo phthalate-13C6,d34 is 13C labeled Bis(2-ethylhexyl) 3,4,5,6-tetrabromophthalate.
    Bis(2-Ethylhexyl)-tetrabromo phthalate-<sup>13</sup>C<sub>6</sub>,d<sub>34</sub>
  • HY-118830S1
    13,14-Dihydro-15-keto prostaglandin D2-d9
    13,14-Dihydro-15-keto prostaglandin D2-d9 (DK-PGD2-d9) is deuterium labeled 13,14-Dihydro-15-keto prostaglandin D2. 13, 14-Dihydro-15-keto prostaglandin D2 (DK-PGD2) is a PGD2 metabolite formed by the 15-hydroxyl PGDH pathway. 13, 14-Dihydro-15-keto prostaglandin D2 is a selective agonist for the DP2 receptor. 13, 14-Dihydro-15-keto prostaglandin D2 can inhibit ion flux in canine colonic mucosa preparation.
    13,14-Dihydro-15-keto prostaglandin D2-d<sub>9</sub>
  • HY-115767S
    (±)-1,2-Diolein-CC3
    (±)-1,2-Diolein-13C3 (1,2-Dioleoyl-rac-glycerol-13C3) is 13C labeled (±)-1,2-Diolein. (±)-1,2-Diolein (1,2-Dioleoyl-rac-glycerol) is a PKC activator. (±)-1,2-Diolein increases myotubes Ca2+ influx.
    (±)-1,2-Diolein-</sup>C<sub>C3
  • HY-W012477S
    1-Hydroxycyclohexyl phenyl ketone-d5
    1-Hydroxycyclohexyl phenyl ketone-d5 (Photoinitiator-184-d5) is the deuterium labeled 1-Hydroxycyclohexyl phenyl ketone (HY-W012477).
    1-Hydroxycyclohexyl phenyl ketone-d<sub>5</sub>
  • HY-B0115S
    Pizotyline-d3
    Pizotyline-d3 is deuterated labeled Pizotifen (HY-B0115). Pizotifen (Pizotyline) is a potent 5-HT2 receptor antagonist, with a high affinity for 5-HT1C binding site.
    Pizotyline-d<sub>3</sub>
  • HY-W653728
    Acrylamide-d3
    Acrylamide-d3 is the deuterium labeled Acrylamide.
    Acrylamide-d<sub>3</sub>
  • HY-17367S5
    Atazanavir-d24
    Atazanavir-d24 (BMS-232632-d24) is deuterium labeled Atazanavir. Atazanavir (BMS-232632) is a highly selective and orally active HIV-1 protease inhibitor . Atazanavir is a substrate and inhibitor of CYP3A4, and an inhibitor of P-glycoprotein (P-gp). Atazanavir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 3.49 μM. Atazanavir inhibits cardiac fibrosis, hyperlipidemia and induces malignant glioma death.
    Atazanavir-d<sub>24</sub>
  • HY-Y1840S
    3-Methoxyphenol-d3
    3-Methoxyphenol-d3 is deuterated labeled 3-Methoxyphenol (HY-Y1840). 3-Methoxyphenol is a phenolic compound that is biologically toxic. 3-Methoxyphenol is systemically absorbed, disrupts the function of the liver, kidneys, central nervous system, and redox processes, and increases levels of Hb, red blood cells, and white blood cells in the body.
    3-Methoxyphenol-d<sub>3</sub>
  • HY-W052253S
    2-(Piperazin-1-yl)pyrimidin-5-ol-d8 ditrifluoroacetate
    2-(Piperazin-1-yl)pyrimidin-5-ol-d8 (2-Piperazin-1-ylpyrimidin-5-ol-d8) diTFA is deuterium-labeled 2-(Piperazin-1-yl)pyrimidin-5-ol (HY-W052253).
    2-(Piperazin-1-yl)pyrimidin-5-ol-d<sub>8</sub> ditrifluoroacetate
  • HY-143811S
    N-Nitroso-DL-proline-d3
    N-Nitroso-DL-proline-d3 is the deuterium labeled N-Nitroso-DL-proline[1].
    N-Nitroso-DL-proline-d<sub>3</sub>
  • HY-W727525
    Donepezil-d7
    Donepezil-d7 (E2020-d7 (free base)) is deuterium labeled Donepezil. Donepezil (E2020 free base) is a specific and potent AChE inhibitor with IC50s of 8.12 nM and 11.6 nM for bovine AChE and human AChE, respectively.
    Donepezil-d<sub>7</sub>
  • HY-W700069
    Gatifloxacin-d4
    Gatifloxacin-d4 is the deuterium labeled Gatifloxacin.
    Gatifloxacin-d<sub>4</sub>
  • HY-B0124S2
    Zonisamide-13C6
    Zonisamide-13C6 (AD 810-13C6) is 13C labeled Zonisamide. Zonisamide (AD 810) is an orally active carbonic anhydrase inhibitor, with Kis of 35.2 and 20.6 nM for hCA II and hCA V, respectively. Zonisamide exerts neuroprotective effects through anti-apoptosis and upregulating MnSOD levels. Zonisamide also increases the expression of Hrd1, thereby improving cardiac function in AAC rats. Zonisamide can be used in studies of seizure, parkinson’s disease and cardiac hypertrophy.
    Zonisamide-<sup>13</sup>C<sub>6</sub>
  • HY-N8016S1
    Nonanal-d4
    Nonanal-d4 is deuterated labeled Nonanal (HY-N8016). Nonanal is a saturated fatty aldehyde with antidiarrhoeal activity.
    Nonanal-d<sub>4</sub>
  • HY-166917S
    1,3,6,8-Tetrachloro-dibenzofuran-13C12
    1,3,6,8-Tetrachloro-dibenzofuran-13C12 is 13C labeled 1,3,6,8-Tetrachlorodibenzofuran.
    1,3,6,8-Tetrachloro-dibenzofuran-<sup>13</sup>C<sub>12</sub>
  • HY-13562S
    Banoxantrone-d12
    Banoxantrone-d12 is the deuterium labeled banoxantrone. Banoxantrone is a novel bioreductive agent that can be reduced to a stable, DNA-affinic compound AQ4, which is a potent topoisomerase II inhibitor.
    Banoxantrone-d<sub>12</sub>